Discover the top 21 companies transforming the medical robots market, including Intuitive Surgical, Stryker, Medtronic, and other industry leaders. Backed by a market projected to grow from $16.0 billion to $33.8 billion by 2029 at a CAGR of 16.1%, this analysis highlights competitive strengths, breakthrough innovations, and strategic moves shaping the future of the industry. Access the full market research report for deeper insights.

Download PDF Brochure:“Click Here”

Spotlights on the Industry’s Top Medical Robots Companies

Intuitive Surgical Inc.

Intuitive Surgical Inc. is the preeminent leader in the global medical robotics market, renowned for its pioneering da Vinci Surgical System. With an installed base exceeding 9,000 units and over 10 million procedures performed, the company has set the industry standard for robotic-assisted minimally invasive surgery. Its ecosystem integrates advanced instrumentation, 3D visualization, and digital analytics to enhance surgeon precision across urology, gynecology, and general surgery. Recent advancements, such as the FDA-cleared da Vinci 5 and the Ion endoluminal system, reinforce Intuitive’s commitment to innovation and market dominance.

Medtronic PLC

Medtronic PLC is a global medical technology giant with a significant and expanding footprint in the surgical robotics sector. The company’s flagship Hugo RAS system offers a modular, mobile-cart design intended to increase procedural flexibility and lower the barrier to entry for hospitals. Additionally, Medtronic leads the spine surgery segment with its Mazor X Stealth Edition, which integrates robotic guidance with advanced 3D imaging and navigation. By leveraging its vast clinical data registries and a “Lab to Life” integrated model, Medtronic is accelerating the adoption of robotic solutions across soft tissue and orthopedic applications.

Stryker Corporation

Stryker Corporation is a dominant force in the orthopedic robotics market, primarily through its Mako SmartRobotics platform. This system utilizes 3D CT-based planning and haptic technology to provide unparalleled precision in total knee, partial knee, and total hip replacements. Stryker continues to aggressively expand its robotic portfolio, recently launching the Mako Total Knee 2.0 and gaining FDA clearance for robotic applications in shoulder and spine surgery. The company’s focus on data-driven clinical outcomes and its extensive global distribution network solidify its position as a top-tier provider of surgical automation.

Johnson & Johnson

Johnson & Johnson is a major competitor in the medical robotics space, driving innovation through its subsidiaries Auris Health and Verb Surgical. Its Monarch Platform is a leader in robotic-assisted bronchoscopy for minimally invasive lung diagnostics, while the upcoming OTTAVA general surgery robot represents its move into the multi-specialty soft-tissue market. J&J’s strategic partnership with Google integrates artificial intelligence and advanced imaging into its surgical ecosystem, aiming to create a digital surgery platform that optimizes clinical workflows and improves patient safety across the surgical continuum.

Zimmer Biomet Holdings, Inc.

Zimmer Biomet is a leading innovator in specialized orthopedic robotics, centered on its ROSA technology. Part of the ZBEdge digital ecosystem, the ROSA platform supports robotic-assisted procedures in knee, hip, and brain surgery, with a recent expansion into shoulder applications following FDA clearance. The system is designed to improve implant placement accuracy and surgical efficiency through real-time intraoperative feedback. With over 120 hospitals globally utilizing its technology, Zimmer Biomet focuses on integrating robotic hardware with data analytics to provide personalized, high-precision orthopedic care.

Siemens Healthineers AG

Siemens Healthineers AG is a world leader in medical imaging and diagnostic technology that has strategically entered the robotics market through the acquisition of Corindus Vascular Robotics. Its CorPath systems provide robotic-assisted solutions for percutaneous coronary and vascular interventions, allowing for precise catheter and stent placement while reducing radiation exposure for clinical staff. Siemens integrates these robotic capabilities with its industry-leading intra-operative imaging and AI-powered diagnostic tools, reinforcing its role in precision medicine and complex interventional neurosurgery.

Abbott Laboratories

Abbott Laboratories is a premier global healthcare leader recognized for its robust diagnostics and medical device portfolio. In the medical robotics sector, Abbott integrates its advanced cardiovascular and neuromodulation technologies with robotic platforms to enhance procedural accuracy and patient outcomes. The company’s commitment to high-throughput, reliable testing and its extensive global reach make it a critical player in the healthcare automation landscape, addressing complex needs in cardiology and chronic disease management through scalable and user-friendly systems.

GE Healthcare

GE Healthcare is a leading global provider of medical imaging, monitoring, and digital solutions that support the integration of robotics in clinical settings. The company specializes in advanced intra-operative imaging systems that serve as the foundational guidance for various surgical robotic platforms. By leveraging artificial intelligence and high-resolution visualization, GE Healthcare enables precise navigation and real-time monitoring during complex robotic procedures, driving efficiency and safety in neurology, cardiology, and oncology applications.

Philips Healthcare

Philips Healthcare is a global leader in health technology focused on improving patient outcomes through integrated solutions and advanced informatics. In the medical robotics market, Philips provides critical support through its image-guided therapy platforms, which facilitate precise navigation for robotic-assisted interventions. The company’s focus on telehealth and remote monitoring, combined with its high-capacity data analytics, enables healthcare providers to optimize the performance of robotic systems and expand access to quality care in both developed and emerging markets.

Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology company that advances the world of health by improving medical discovery and the delivery of care. While primarily known for its dominance in microbiology and molecular diagnostics, BD is active in the robotics space through strategic investments and the integration of automation into hospital workflows. Its BD Cato software solution allows for the seamless integration of robotic compounding devices into existing hospital IT infrastructures, improving medication safety and operational efficiency in pharmacy and clinical settings.

Boston Scientific Corporation

Boston Scientific Corporation is a leading manufacturer of medical devices used in a wide range of interventional medical specialties. In the robotics sector, the company focuses on developing and integrating technologies that enhance the precision of minimally invasive procedures. By collaborating with robotic platforms and investing in smart instrumentation, Boston Scientific supports advanced treatments in cardiology, urology, and endoscopy, helping clinicians navigate complex anatomical structures with greater control and accuracy.

Accuray Incorporated

Accuray Incorporated is a specialized radiation oncology company that utilizes robotic technology to deliver high-precision cancer treatments. Its flagship CyberKnife System is a fully robotic radiation delivery platform that uses real-time image guidance to track and adjust for tumor motion, allowing for non-invasive treatments with sub-millimeter accuracy. Accuray’s focus on robotic radiosurgery positions it as a critical player in the oncology market, providing effective alternatives to traditional surgery for complex and hard-to-reach tumors.

Auris Surgical Robotics, Inc.

Auris Surgical Robotics, Inc., a subsidiary of Johnson & Johnson, is a pioneer in the field of endoluminal robotics. The company is best known for the Monarch Platform, a robotic-assisted system designed to navigate the lung’s peripheral anatomy for earlier and more accurate diagnosis of nodules. By combining traditional endoscopic capabilities with robotic precision and computer-assisted navigation, Auris is transforming the diagnostic pathway for lung cancer and expanding the potential for minimally invasive interventions in respiratory health.

Medrobotics Corporation

Medrobotics Corporation is a medical device company that has developed the Flex Robotic System, the first robotic-assisted surgical platform with a steerable and shape-correcting scope. This unique technology allows surgeons to access hard-to-reach anatomical locations through a single site, particularly in transoral and transanal procedures. Medrobotics focuses on providing clinicians with high-definition visualization and flexible instrumentation, enabling minimally invasive surgery in complex areas that were previously difficult to navigate with rigid robotic systems.

iRobot Corporation

iRobot Corporation, while primarily known for its consumer robotics, has historically contributed to the medical field through the development of telepresence and assistive robotic technologies. Its presence in the healthcare market has focused on utilizing autonomous navigation and remote communication platforms to facilitate doctor-patient interactions and hospital logistics. iRobot’s expertise in robotic mobility and sensor integration continues to influence the development of geriatric and assistive robots designed to support independent living and clinical efficiency.

Cyberdyne Inc.

Cyberdyne Inc. is a Japanese robotics company at the forefront of the exoskeleton and rehabilitative robot market. Its signature product, the HAL (Hybrid Assistive Limb), is a wearable cyborg that uses bio-electrical signals to assist and enhance the wearer’s physical movements. Cyberdyne focuses on medical applications for spinal cord injuries, stroke recovery, and neuromuscular diseases, providing innovative solutions that promote functional recovery and improve the quality of life for patients with mobility impairments.

Smith & Nephew PLC

Smith & Nephew PLC is a leading global medical technology company that specializes in orthopedic reconstruction, advanced wound management, and sports medicine. Its medical robotics portfolio is centered on the CORI surgical system, a compact and portable handheld robotic solution for knee arthroplasty. Unlike fixed-tower systems, CORI is designed for ease of use in ambulatory surgery centers and outpatient clinics. Smith & Nephew’s commitment to flexible, cost-effective automation supports the growing trend of outpatient robotic surgery.

Hansen Medical, Inc.

Hansen Medical, Inc., now part of Auris Health (Johnson & Johnson), was a pioneer in the development of intravascular robotic systems. The company specialized in the design of flexible, steerable catheters for the precise navigation of the cardiovascular system. Its Magellan and Sensei robotic platforms provided clinicians with enhanced control and stability during complex electrophysiology and vascular procedures. The foundational technology developed by Hansen Medical continues to inform the development of next-generation robotic-assisted endovascular therapies.

Titan Medical Inc.

Titan Medical Inc. is a Canadian medical device company focused on the development of a single-port robotic surgical system. Its Enos platform is designed to provide surgeons with dual-view visualization and multi-articulated instruments through a single incision, aiming to simplify complex procedures and minimize patient trauma. Titan Medical targets the growing demand for single-access robotic surgery, positioning its technology as a versatile and cost-effective solution for a variety of abdominal and pelvic procedures.

Download PDF Brochure:“Click Here”